On April 15, 2021, Aceto, a global provider of specialty materials in the life sciences and advanced technology markets, announced its acquisition of A&C, a GMP (Good Manufacturing Practices) manufacturer specializing in providing pharmaceutical ingredients to the global life sciences industry. The acquisition drives Aceto’s growth strategy by increasing its GMP manufacturing, packaging and ingredients offerings and will allow Aceto to provide its customers with greater access to materials used in the cell culture, vaccine and biopharmaceutical industries. The transaction will also allow Aceto to expand its footprint in North America.
Osler, Hoskin & Harcourt LLP advised Aceto with a team consisting of Shahir Guindi, Matthew Oliver, Véronique Fortin-Latreille (Corporate), Julien Ranger (Pensions & Benefits), Susan Newell (Health), Manon Thivierge (Taxation), Caroline Stephens (Real Estate), Patrick Welsh (Environment), Sam Ip (Technology), Kelly Moffatt (Commercial) and Danielle Chu (Competition/Antitrust & Foreign Investment).
Key Contact
Former National Co-Chair, Partner, Corporate, Montréal
Team
Associate, Competition, Trade and Foreign Investment, Toronto
Partner, Pensions and Benefits, Montréal
Partner, Commercial, Toronto
Partner, Tax, Montréal
Partner, Technology, Toronto
Partner, Corporate, Montréal
Associate, Real Estate, Montréal
Associate, Corporate, Montréal
Partner, Health, Toronto
